Michiko K Oyoshi1, Jacqueline Beaupré2, Nicholas Venturelli2, Christopher N Lewis2, Yoichiro Iwakura3, Raif S Geha2. 1. Division of Immunology, Boston Children's Hospital and the Department of Medicine, Harvard Medical School, Boston, Mass. Electronic address: michiko.oyoshi@childrens.harvard.edu. 2. Division of Immunology, Boston Children's Hospital and the Department of Medicine, Harvard Medical School, Boston, Mass. 3. Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
Abstract
BACKGROUND: Eczema vaccinatum is a life-threatening complication of smallpox vaccination in patients with atopic dermatitis (AD) characterized by dissemination of vaccinia virus (VV) in the skin and internal organs. Mutations in the filaggrin (FLG) gene, the most common genetic risk factor for AD, confer a greater risk for eczema herpeticum in patients with AD, suggesting that it impairs the response to cutaneous viral infections. OBJECTIVE: We sought to determine the effects of FLG deficiency on the response of mice to cutaneous VV inoculation. METHODS: VV was inoculated by means of scarification of unsensitized skin or skin topically sensitized with ovalbumin in FLG-deficient flaky tail (ft/ft) mice or wild-type (WT) control mice. The sizes of primary and satellite skin lesions were measured, and hematoxylin and eosin staining was performed. VV genome copy numbers and cytokine mRNA levels were measured by using quantitative PCR. RESULTS: VV inoculation in unsensitized skin of ft/ft mice, independent of the matted hair mutation, resulted in larger primary lesions, more abundant satellite lesions, heavier viral loads in internal organs, greater epidermal thickness, dermal cellular infiltration, and higher local Il17a, Il4, Il13, and Ifng mRNA levels than in WT control mice. VV inoculation at sites of topical ovalbumin application amplified all of these features in ft/ft mice but had no detectable effect in WT control mice. The number of satellite lesions and the viral loads in internal organs after cutaneous VV inoculation were significantly reduced in both unsensitized and topically sensitized ft/ftxIl17a(-/-) mice. CONCLUSION: FLG deficiency predisposes to eczema vaccinatum. This is mediated primarily through production of IL-17A.
BACKGROUND: Eczema vaccinatum is a life-threatening complication of smallpox vaccination in patients with atopic dermatitis (AD) characterized by dissemination of vaccinia virus (VV) in the skin and internal organs. Mutations in the filaggrin (FLG) gene, the most common genetic risk factor for AD, confer a greater risk for eczema herpeticum in patients with AD, suggesting that it impairs the response to cutaneous viral infections. OBJECTIVE: We sought to determine the effects of FLG deficiency on the response of mice to cutaneous VV inoculation. METHODS: VV was inoculated by means of scarification of unsensitized skin or skin topically sensitized with ovalbumin in FLG-deficient flaky tail (ft/ft) mice or wild-type (WT) control mice. The sizes of primary and satellite skin lesions were measured, and hematoxylin and eosin staining was performed. VV genome copy numbers and cytokine mRNA levels were measured by using quantitative PCR. RESULTS: VV inoculation in unsensitized skin of ft/ft mice, independent of the matted hair mutation, resulted in larger primary lesions, more abundant satellite lesions, heavier viral loads in internal organs, greater epidermal thickness, dermal cellular infiltration, and higher local Il17a, Il4, Il13, and Ifng mRNA levels than in WT control mice. VV inoculation at sites of topical ovalbumin application amplified all of these features in ft/ft mice but had no detectable effect in WT control mice. The number of satellite lesions and the viral loads in internal organs after cutaneous VV inoculation were significantly reduced in both unsensitized and topically sensitized ft/ftxIl17a(-/-) mice. CONCLUSION: FLG deficiency predisposes to eczema vaccinatum. This is mediated primarily through production of IL-17A.
Authors: Donald Y M Leung; Pei-Song Gao; Dmitry N Grigoryev; Nicholas M Rafaels; Joanne E Streib; Michael D Howell; Patricia A Taylor; Mark Boguniewicz; Jennifer Canniff; Brian Armstrong; Daniel J Zaccaro; Lynda C Schneider; Tissa R Hata; Jon M Hanifin; Lisa A Beck; Adriana Weinberg; Kathleen C Barnes Journal: J Allergy Clin Immunol Date: 2011-04 Impact factor: 10.793
Authors: Jamie Tanzer; Di Meng; Asa Ohsaki; Julie M Caldwell; Melissa K Mingler; Marc E Rothenberg; Michiko K Oyoshi Journal: PLoS One Date: 2022-06-27 Impact factor: 3.752
Authors: Evgeny Berdyshev; Elena Goleva; Irina Bronova; Anna Sofia Bronoff; Joanne E Streib; Kathryn A Vang; Brittany N Richers; Patricia Taylor; Lisa Beck; Miguel Villarreal; Keli Johnson; Gloria David; Mark K Slifka; Jon Hanifin; Donald Y M Leung Journal: J Allergy Clin Immunol Date: 2022-03-15 Impact factor: 14.290
Authors: Nathan K Archer; Jay-Hyun Jo; Steven K Lee; Dongwon Kim; Barbara Smith; Roger V Ortines; Yu Wang; Mark C Marchitto; Advaitaa Ravipati; Shuting S Cai; Carly A Dillen; Haiyun Liu; Robert J Miller; Alyssa G Ashbaugh; Angad S Uppal; Michiko K Oyoshi; Nidhi Malhotra; Sabine Hoff; Luis A Garza; Heidi H Kong; Julia A Segre; Raif S Geha; Lloyd S Miller Journal: J Allergy Clin Immunol Date: 2018-09-19 Impact factor: 10.793